Page last updated: 2024-10-23

5-methoxypsoralen and Ischemic Stroke

5-methoxypsoralen has been researched along with Ischemic Stroke in 1 studies

5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.

Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gao, S1
Zou, X1
Wang, Z1
Shu, X1
Cao, X1
Xia, S1
Shao, P1
Bao, X1
Yang, H1
Xu, Y1
Liu, P1

Other Studies

1 other study available for 5-methoxypsoralen and Ischemic Stroke

ArticleYear
Bergapten attenuates microglia-mediated neuroinflammation and ischemic brain injury by targeting Kv1.3 and Carbonyl reductase 1.
    European journal of pharmacology, 2022, Oct-15, Volume: 933

    Topics: 5-Methoxypsoralen; Anti-Inflammatory Agents; Brain Injuries; Carbonyl Reductase (NADPH); Cytokines;

2022